Key Points From the 2016 NIOSH List of Antineoplastic and Hazardous Drugs in Health Care Settings
March 20th 2018In response to the numerous concerns regarding antineoplastic drugs and other medications that may threaten the health of patients and health care workers, the National Institute for Occupational Safety and Health (NIOSH) developed a list, updated biennially, of hazardous drugs.
Read More
Key Points to Consider From USP
January 25th 2018Each year, more than 8 million U.S. health care personnel are potentially exposed to hazardous medications. Acute and chronic health effects have been reported, including headaches, ocular problems, rashes, hair loss, adverse reproductive health, and increased cancer risk.
Read More